rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-4-19
|
pubmed:abstractText |
Cutaneous leishmaniasis (CL) is a parasitic disease caused by Leishmania species. There is a need for more effective and less time-consuming therapeutic methods for this condition.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0011-9059
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
281-3
|
pubmed:dateRevised |
2006-10-30
|
pubmed:meshHeading |
pubmed-meshheading:15090013-Adult,
pubmed-meshheading:15090013-Antiprotozoal Agents,
pubmed-meshheading:15090013-Combined Modality Therapy,
pubmed-meshheading:15090013-Cryotherapy,
pubmed-meshheading:15090013-Female,
pubmed-meshheading:15090013-Humans,
pubmed-meshheading:15090013-Injections, Intralesional,
pubmed-meshheading:15090013-Leishmaniasis, Cutaneous,
pubmed-meshheading:15090013-Male,
pubmed-meshheading:15090013-Meglumine,
pubmed-meshheading:15090013-Organometallic Compounds,
pubmed-meshheading:15090013-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
|
pubmed:affiliation |
Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|